NEO · Neogenomics Inc
United States · RS rating 83 · As of 2026-11-03
| Price | 16.83 USD |
|---|---|
| 1-day change | +2.1% |
| RS rating (overall / 1M / 3M / 12M) | 83 / 32 / 79 / 90 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 46 / 48 / 63 |
| Industry group (rank) | Medical-Services (63) |
| EPS growth Q/Q | +61.9% |
| Sales growth Q/Q | +1.3% |
| Distance from 52-week high | +15.5% |
| Market cap (USD) | $1.0B |